Filing Flows › Prokidney (PROK) › Q2 2026
Prokidney (PROK) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 10, 2026
Prokidney (PROK) reported revenue of $150K for the second quarter 2026 (Q2 2026), -32% from a year earlier and -34% from the quarter before.
Prokidney, Q2 2026: revenue $150K (-32% year over year), net loss $46.4M, operating cash flow −$40.4M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $150K | -34% | -32% |
| Operating profit | −$48.4M | — | — |
| Net earnings | −$46.4M | — | — |
| Operating cash flow | −$40.4M | — | — |
What changed
Revenue was $150K in Q2 2026, down 32% year over year and down 34% from the previous quarter.
Operating costs exceeded revenue by $48.4M, an operating margin of -32248.7%. Total costs grew 22% against a revenue fall of 32%. The fastest-growing cost line was Research & development (+39%). The quarter ended with a net loss of $46.4M, wider than the previous quarter's $42.6M loss. Minority interests bore $18.0M of it: to shareholders the quarter was a loss of $28.4M.
Operating cash flow was −$40.4M. Non-cash charges added back $1.7M of depreciation and amortization and $5.6M of share-based compensation. Capital expenditures of $3.8M exceeded it, leaving free cash flow of −$44.2M.
Questions
What was Prokidney's revenue in the second quarter 2026?
Prokidney (PROK) reported revenue of $150K for the second quarter 2026 (Q2 2026), -32% from a year earlier and -34% from the quarter before.
Source: Prokidney 10-Q on SEC EDGAR.